Elise C. Kohn, MD
Senior Investigator and Head, Gynecologic Therapeutics
National Cancer Institute
9609 Medical Center Drive
Bethesda,
MD
USA
20892-9737
Biographical Sketch: Dr. Kohn trained in medicine and Internal Medicine at the University of Michigan Medical School before coming to the National Cancer Institute for her medical oncology fellowship. Dr. Kohn has been at the NCI, investigating therapeutic targets in the signaling of invasion and angiogenesis and drug development focused for ovarian cancer patients while maintaining a clinical program in early phase clinical trials for ovarian cancer. In parallel, her clinical work has evolved to include the newest targeted therapies and proteomic technologies applied to clinical trials."
Papers:
257 - Poster Session A
Development of flow cytometric predictive biomarker assay for response to PARP inhibitor (PARPi) therapy in high-grade serous ovarian cancer (HGSOC)
Lecturette